Seer (SEER) Accumulated Expenses (2020 - 2026)
Seer (SEER) recorded quarterly Accumulated Expenses of $1.0 million in Q1 2026, down 28.57% quarter-over-quarter from $1.4 million in Q4 2025, and down 83.62% on a YoY basis from $6.1 million in Q1 2025.
Seer (SEER) Accumulated Expenses (2020 - 2026) Analysis & Trends
Seer's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Accumulated Expenses fell 83.62% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 83.62% YoY), while the FY2025 annual figure was $1.4 million, up 19.25% from the prior year.
- Accumulated Expenses was $1.0 million for Q1 2026 at Seer, down from $1.4 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $9.1 million in Q3 2023 to a low of $912000.0 in Q3 2025.
- Historically, Accumulated Expenses has averaged $4.9 million across 5 years, with a median of $5.9 million in 2024.
- Biggest YoY gain for Accumulated Expenses was 125.23% in 2025; the steepest drop was 84.59% in 2025.
- A 5-year view of Accumulated Expenses shows it stood at $6.1 million in 2022, then tumbled by 61.79% to $2.3 million in 2023, then tumbled by 49.96% to $1.2 million in 2024, then grew by 19.25% to $1.4 million in 2025, then decreased by 28.57% to $1.0 million in 2026.
- The last three Accumulated Expenses figures came in at $1.0 million (Q1 2026), $1.4 million (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2025 | 4.53 Mn |
| Mar 31, 2025 | 6.11 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 5.92 Mn |
| Jun 30, 2024 | 3.15 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Sep 30, 2023 | 9.15 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Mar 31, 2023 | 7.18 Mn |
| Dec 31, 2022 | 6.14 Mn |
| Sep 30, 2022 | 7.82 Mn |
| Jun 30, 2022 | 9.14 Mn |
| Mar 31, 2022 | 6.38 Mn |
| Dec 31, 2021 | 8.39 Mn |
| Sep 30, 2021 | 5.97 Mn |
| Jun 30, 2021 | 5.59 Mn |